Meyka AI API is live for developers.Start building.
Advertisement
Ascentage Pharma Group International

Ascentage Pharma Group International (AAPGV) Stock Overview

Explore Ascentage Pharma Group International’s financial performance, market position, analyst ratings, and future outlook.

AAPGV●PNK
HealthcareBiotechnology
$17.38
$0.13(0.75%)
U.S. Market opens in NaNh NaNm
Advertisement

Ascentage Pharma Group International (AAPGV)

Meyka AI Score

Z

Key Financials

Market Cap127.3M
P/E Ratio-21.90
EPS (TTM)N/A
ROE-2.50%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

AAPGV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ascentage Pharma Group International (AAPGV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -21.90 and a market capitalization of 127.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-6.31%
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

https://www.ascentage.cn
86 512 8555 7777
Suzhou Industrial Park, Suzhou, NaN, 215000

Company Facts

5,740 Employees
IPO DateJan 24, 2025
CountryCN

Frequently Asked Questions